NASDAQ:CSII
Delisted
Cardiovascular Systems Stock News
$20.00
+0 (+0%)
At Close: Jul 26, 2023
Cardiovascular Systems Expects COVID-19 Impact On Quarterly Revenue
01:57pm, Wednesday, 22'nd Sep 2021
Cardiovascular Systems Inc (NASDAQ: CSII) issued an update on financials citing the COVID-19 impact. The device maker says that the revenue for Q1 FY22 could be negatively affected by more than 10%
Cardiovascular Systems (CSII) Introduces Diamondback in Canada
11:25am, Tuesday, 31'st Aug 2021
The introduction of Cardiovascular Systems' (CSII) Diamondback 360 Coronary OAS in Canada will offer physicians an effective treatment option for patients with coronary artery diseases.
First Patients in Canada Treated With Cardiovascular Systems, Inc. Diamondback 360® Coronary Orbital Atherectomy System
04:05pm, Monday, 30'th Aug 2021
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients
Cardiovascular Systems' (CSII) CEO Scott Ward on Q4 2021 Results - Earnings Call Transcript
08:41am, Sunday, 08'th Aug 2021
Cardiovascular Systems' (CSII) CEO Scott Ward on Q4 2021 Results - Earnings Call Transcript
Cardiovascular Systems, Inc. to Attend Three Investor Conferences in August
07:00am, Tuesday, 27'th Jul 2021
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients
Cardiovascular Systems stock drops after CMS proposes payment cuts, but Needham says buy on weakness
02:48pm, Thursday, 15'th Jul 2021
Shares of Cardiovascular Systems Inc. , a medical device company focused on treatments for vascular and coronary disease, tumbled 10.2% in afternoon trading, and has dropped 18.1% amid a four-day losi
Cardiovascular Systems (CSII) Coronary Arm Grows, Margin Dips
11:16am, Friday, 21'st May 2021
Cardiovascular Systems (CSII) is progressing well with its objective to introduce OAS globally.
Cardiovascular Systems (CSII) Coronary OAS Study Data Favorable
09:46am, Friday, 21'st May 2021
Cardiovascular Systems' (CSII) Diamondback 360 Coronary OAS helps in restoring native vessel compliance, simplify procedural workflow and enhance percutaneous coronary intervention outcomes.
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients
Cardiovascular Systems (CSII) Q3 Loss Widens, Gross Margin Dips
12:02pm, Tuesday, 11'th May 2021
Increase in vaccinations and simultaneous decrease in COVID-19 hospitalizations in February and March result in improved procedure volumes for Cardiovascular Systems (CSII) in Q3.
Cardiovascular Systems, Inc. (CSII) CEO Scott Ward on Q3 2021 Results - Earnings Call Transcript
01:53am, Sunday, 09'th May 2021
Cardiovascular Systems, Inc. (CSII) CEO Scott Ward on Q3 2021 Results - Earnings Call Transcript
Cardiovascular Systems (CSII) Reports Q3 Loss, Misses Revenue Estimates
06:47pm, Thursday, 06'th May 2021
Cardiovascular Systems (CSII) delivered earnings and revenue surprises of -50.00% and -0.25%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock
Cardiovascular Systems, Inc. to Webcast Fiscal 2021 Third-Quarter Earnings Conference Call Thursday, May 6
07:00pm, Thursday, 15'th Apr 2021
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will host a live webcast of its fiscal 2021 third-quarter conference call on Thursday, May 6, 2021, at 3:30 p.m. C
Cardiovascular Systems (CSII) Inks Deal to Enhance Patient Care
09:05am, Friday, 09'th Apr 2021
Cardiovascular Systems' (CSII) investment in CarePICS will advance patient access to the suitable treatment at the right time, thereby leading to improved care and reduced amputations.
5 MedTech Growth Stocks Gaining Ground in 2021 Amid Pandemic
09:51am, Thursday, 25'th Mar 2021
Here are a few MedTech stocks, ABT, HOLX, HRC, IDXX, LMAT, which have held their ground amid the pandemic and can turn out to be wise investment choices for 2021.